Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) · 2026
[Psychological psychotherapists' and physicians' perspective on perceived need for and prescription of digital health applications for mental disorders].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Engesser Deborah, Stalujanis Esther, Kemmerer Pascal, Dotzauer Lena, Salm Sandra, Scheibe Sandy, Mergenthal Karola, Voigt Karen, Singer Susanne
Аннотация
Since 2020, psychotherapists and physicians have been allowed to prescribe digital health applications for mental disorders (DHA-MD). The aim of the study was to examine the actual relevance of DHA-MD for mental health care by asking psychotherapists and physicians for their opinion on the need for DHA-MD and how often they actually prescribe them. Moreover, we wanted to identify reasons for (not) prescribing DHA-MD.In spring 2024, 1000 psychological psychotherapists and physicians registered by the National Association of Statutory Health Insurance Physicians in Germany were selected stratified by region and community size. They received a self-developed questionnaire by post, which was additionally published online by, for instance, expert associations. Additionally, we conducted semi-structured interviews with selected participants. Questionnaires were analysed both descriptively and via Spearman's Rank Correlation Test. A qualitative content analysis according to Mayring was done for the interviews.In total, 321 participants filled out the questionnaires, and 16 were interviewed. The need for DHA-MD on a scale of 0-10 was rated≤2 (median 2) by 61% (n=198) of the participants. The median of DHA-MD prescriptions in a regular calender quarter was 0 with a range up to 20. The share of participants prescribing at least one PsyDiGA was slightly higher (n=23, 29%) among physicians compared to psychological psychotherapists (n=60, 25%). There was no difference in the assessment of need for DHA-MD between the two professions. According to the interviews, requirements for confidence in and prescription of DHA-MD comprised guaranteed data protection, sufficient proof of concept, and knowledge about the contents of DHA-MD.Reasons for the low number of prescriptions and perceived need for DHA-MD may be less experience with DHA-MD or a lack of perceived necessity in participants' practice routine. The demand for transparency concerning data protection, proof of concept, and content of DHA-MD show mental health professionals' expectations of high quality concerning DHA-MD.